-
Bioorg. Med. Chem. Lett. · Dec 2012
Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2.
- Sharada Labadie, Peter S Dragovich, Kathy Barrett, Wade S Blair, Philippe Bergeron, Christine Chang, Gauri Deshmukh, Charles Eigenbrot, Nico Ghilardi, Paul Gibbons, Christopher A Hurley, Adam Johnson, Jane R Kenny, KohliPawan BirPB, Janusz J Kulagowski, Marya Liimatta, Patrick J Lupardus, Rohan Mendonca, Jeremy M Murray, Rebecca Pulk, Steven Shia, Micah Steffek, Savita Ubhayakar, Mark Ultsch, Anne van Abbema, Stuart Ward, and Mark Zak.
- Small Molecule Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States. sharadal@gene.com
- Bioorg. Med. Chem. Lett. 2012 Dec 15; 22 (24): 7627-33.
AbstractHerein we describe our successful efforts in obtaining C-2 substituted imidazo-pyrrolopyridines with improved JAK1 selectivity relative to JAK2 by targeting an amino acid residue that differs between the two isoforms (JAK1: E966; JAK2: D939). Efforts to improve cellular potency by reducing the polarity of the inhibitors are also detailed. The X-ray crystal structure of a representative inhibitor in complex with the JAK1 enzyme is also disclosed.Copyright © 2012 Elsevier Ltd. All rights reserved.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.